DEBBANE RAYMOND Insider Trading Activity (LXRX)

Summary

Updated Jul 16, 2026

DEBBANE RAYMOND has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $723K. Historical track record: 5/5 stars across 7 tracked purchases.

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating	★★★★★ (5/5)
Total purchases tracked	7
Purchases with forward-return data	7
30-day win rate	10000%
90-day win rate	10000%
Avg 5-day return	+518.17%
Avg 30-day return	+1493.25%
Avg 90-day return	+5317.14%
Best 30-day return	+2290.08%

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-04	LXRX	LEXICON PHARMACEUTICALS, INC.	M — Option exercise	89.3K	$0.00
2026-02-27	LXRX	LEXICON PHARMACEUTICALS, INC.	P — Open-market purchase	2.0K	$1.49	$3K
2026-02-25	LXRX	LEXICON PHARMACEUTICALS, INC.	P — Open-market purchase	100.0K	$1.47	$147K
2026-02-23	LXRX	LEXICON PHARMACEUTICALS, INC.	P — Open-market purchase	100.0K	$1.48	$148K
2026-02-23	LXRX	LEXICON PHARMACEUTICALS, INC.	P — Open-market purchase	50.0K	$1.44	$72K
2026-02-18	LXRX	LEXICON PHARMACEUTICALS, INC.	P — Open-market purchase	133.7K	$1.32	$176K
2026-02-18	LXRX	LEXICON PHARMACEUTICALS, INC.	P — Open-market purchase	76.9K	$1.31	$101K
2026-02-18	LXRX	LEXICON PHARMACEUTICALS, INC.	P — Open-market purchase	58.0K	$1.31	$76K
2025-05-13	LXRX	LEXICON PHARMACEUTICALS, INC.	M — Option exercise	36.8K	$0.00

Frequently Asked Questions

Who is DEBBANE RAYMOND?

DEBBANE RAYMOND is a corporate insider — currently tracked as Director of LEXICON PHARMACEUTICALS, INC. (LXRX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has DEBBANE RAYMOND submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has DEBBANE RAYMOND been buying or selling stock?

Recorded transactions: 7 open-market purchases ($723K) and 0 open-market sales () across all tracked filings.

How accurate is DEBBANE RAYMOND's historical track record?

Across 7 tracked purchases, DEBBANE RAYMOND averaged +1493.2% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.

Where can I see all of DEBBANE RAYMOND's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

DEBBANE RAYMOND — SEC Form 4 Insider Trading Activity